Table of Content
Introduction
sopharyngeal Cancer - Overview
sopharyngeal Cancer - Therapeutics Development
sopharyngeal Cancer - Therapeutics Assessment
sopharyngeal Cancer - Companies Involved in Therapeutics Development
sopharyngeal Cancer - Drug Profiles
sopharyngeal Cancer - Dormant Projects
sopharyngeal Cancer - Discontinued Products
sopharyngeal Cancer - Product Development Milestones
Appendix
List of Figures
List of Figures
Number of Products under Development for Nasopharyngeal Cancer, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021
List of Tables
List of Tables
Number of Products under Development for Nasopharyngeal Cancer, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Nasopharyngeal Cancer - Pipeline by ADC Therapeutics SA, 2021
Nasopharyngeal Cancer - Pipeline by Advenchen Laboratories LLC, 2021
Nasopharyngeal Cancer - Pipeline by Akeso Inc, 2021
Nasopharyngeal Cancer - Pipeline by Alphamab Oncology, 2021
Nasopharyngeal Cancer - Pipeline by Ambrx Biopharma Inc, 2021
Nasopharyngeal Cancer - Pipeline by Apollomics Inc, 2021
Nasopharyngeal Cancer - Pipeline by Argenx SE, 2021
Nasopharyngeal Cancer - Pipeline by Ascentage Pharma Group International, 2021
Nasopharyngeal Cancer - Pipeline by AstraZeneca Plc, 2021
Nasopharyngeal Cancer - Pipeline by Atara Biotherapeutics Inc, 2021
Nasopharyngeal Cancer - Pipeline by AVEO Pharmaceuticals Inc, 2021
Nasopharyngeal Cancer - Pipeline by BeiGene Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Biomics Biotechnologies Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by BioSyngen Pte Ltd, 2021
Nasopharyngeal Cancer - Pipeline by BP InnoMed Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Bristol-Myers Squibb Co, 2021
Nasopharyngeal Cancer - Pipeline by Chengdu Wonho Biology Engineering Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by China Immunotech Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by CytoMed Therapeutics Pte Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Eli Lilly and Co, 2021
Nasopharyngeal Cancer - Pipeline by Eutilex Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Exelixis Inc, 2021
Nasopharyngeal Cancer - Pipeline by F. Hoffmann-La Roche Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Geneius Biotechnology Inc, 2021
Nasopharyngeal Cancer - Pipeline by GenFleet Therapeutics (Shanghai) Inc, 2021
Nasopharyngeal Cancer - Pipeline by Genrix (Shanghai) Biopharmaceutical Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Guangzhou Bairui Biomedical Technology Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Guangzhou Doublle Bioproduct Inc, 2021
Nasopharyngeal Cancer - Pipeline by Guangzhou Hanghua Bio Pharmaceutical Technology Co, 2021
Nasopharyngeal Cancer - Pipeline by Harbin Gloria Pharmaceuticals Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Huabo Biopharm (Shanghai) Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Immunomic Therapeutics Inc, 2021
Nasopharyngeal Cancer - Pipeline by Incyte Corp, 2021
Nasopharyngeal Cancer - Pipeline by Inhibrx Inc, 2021
Nasopharyngeal Cancer - Pipeline by Innovent Biologics Inc, 2021
Nasopharyngeal Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Joint Biosciences Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Kuur Therapeutics Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Lion TCR Pte Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Merck KGaA, 2021
Nasopharyngeal Cancer - Pipeline by Nanjing Iaso Biotherapeutics Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Neonc Technologies Inc, 2021
Nasopharyngeal Cancer - Pipeline by Novartis AG, 2021
Nasopharyngeal Cancer - Pipeline by Noxopharm Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Ono Pharmaceutical Co Ltd, 2021
Nasopharyngeal Cancer - Pipeline by Oxford Vacmedix UK Ltd, 2021
Nasopharyngeal Cancer - Pipeline by PNP Therapeutics Inc, 2021
Nasopharyngeal Cancer - Pipeline by Polaris Pharmaceuticals Inc, 2021
Nasopharyngeal Cancer - Dormant Projects, 2021
Nasopharyngeal Cancer - Discontinued Products, 2021